Back to results
US 2025/0017924 A1Published application
Pharmaceutical compositions
AssigneeViiV Healthcare Company
InventorsDeepak B. MUNDHRA, Rennan PAN
Life of this patent
Estimating the term…
Abstract
The present Invention relates to pharmaceutical compositions of (3S,11aR)-N-[(2,4-difluorophenyl)methyl]2,3,5,7,11,11a-hexahydro-6-hydroxy-3-methyl-5,7-dioxo-oxazolo[3,2-a]pyrido[1,2-d] pyrazine-8-carboxamide, useful in the treatment or prevention of Human Immunodeficiency Virus (HIV) infections.
Claims30
A parenteral pharmaceutical suspension comprising 0.1-50% by weight a compound of formula (I)
- 0.1-10% by weight polysorbate,
- 0.1-10% by weight polyethylene glycol 3350, 4000 or 8000,
- mannitol, and
- water, and
- wherein the suspension has a X50 particle size of <200 nm.
2 more elements
Dependencies are inferred from the claim text.